Puragen Life Sciences Division

International Precious Metals Institute 32^nd Annual Conference of Precious Metals
June 6 - 10, 2008 in Phoenix, Arizona.
IBC will present a paper about precious metals recovery

Puragen Life Sciences Division

IBC is active in the development of new products for the biotechnology, pharmaceutical and medical industries. A few of these applications include:

Enantiomeric Separations

Separations technology for the analysis and production of chiral drugs, amino acids, intermediates, agrochemicals, and other intermediates.

Nucleic Acid Separations

Separations technology for the analysis and production of antisense drugs, oligonucleotides, primers, genomic DNA.

Clinical Blood Electrolyte Sensors

Sensing technology for measurement of critical blood electrolyte components.

Imaging and/or Therapy with Medical Isotopes

Chelation technology for alpha, beta and gamma emitter radioisotopes useful for medical diagnostics and therapy. IBC was awarded an NIH SBIR grant entitled: "Rubidium-82 Complexes for Positron Emission Tomography".

Peptide and Protein Separations

Separation of peptide mixtures, protein digests, and recombinent proteins. IBC was awarded an NIH SBIR grant entitled "Novel Metal Affinity Peptide and Protein Separations".

The following press releases are from the Advanced Technology Program, National Institute of Standards and Technology (NIST). Click on the PDF icon to view Adobe Acrobat file.

	Non-Chromatographic Enantiomer Separation & Purification with High Separation Factors

	Efficient Low-Cost Manufacture of Oligonucleotides Using Non-Chromatographic Purification

Inquiries:

For inquiries about how IBC may be able to help you with a specific product or application, please contact us at 801.763.8400 or e-mail us at info@ibcmrt.com.